Tobias Heinrich

In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, ¹⁸F-Labeled Deuterated Fluorodeprenyl

Sangram Nag, Patrik Fazio, Lutz Lehmann et al. · Journal of Nuclear Medicine · 2015 · 82 citations · Full text

Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer’s disease patients and control subjects

Andrea Varrone, Vesa Oikonen, Anton Forsberg et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 77 citations · Full text

Positron Emission Tomography, Neuroimaging Biomarkers, Neurodegenerative Diseases +9

Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability

Adrienne Müller, Stefanie D. Krämer, Romana Meletta et al. · Nuclear Medicine and Biology · 2014 · 49 citations

Inflammation, Vascular Disease, Engineering +14

Development of a novel fluorine-18 labeled deuterated fluororasagiline ([18F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B)

Sangram Nag, Lutz Lehmann, Georg Kettschau et al. · Bioorganic & Medicinal Chemistry · 2013 · 46 citations · Full text

Medicinal Chemistry, Bioorganic Chemistry, Biochemistry +9

Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor

Julien Lefranc, Volker Schulze, R.C. Hillig et al. · Journal of Medicinal Chemistry · 2019 · 46 citations · Full text

Serine/threonine Kinase Tbk1, Immunology, Cancer Biology +17